The article discusses the closure of a same-day emergency care (SDEC) unit for patients with sickle cell disease at the Royal London Hospital. The SDEC trial, which was praised by patients and experts, provided specialized care for this patient population. However, the unit has now been shut down, leaving sickle cell patients uncertain about their access to timely and appropriate emergency services. The article highlights the potential impact of this change on the management of sickle cell disease and the need for continued support for this patient group.